These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21142704)

  • 41. Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.
    Heber EM; Trivillin VA; Nigg DW; Itoiz ME; Gonzalez BN; Rebagliati RJ; Batistoni D; Kreimann EL; Schwint AE
    Arch Oral Biol; 2006 Oct; 51(10):922-9. PubMed ID: 16696934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BNCT of 3 cases of spontaneous head and neck cancer in feline patients.
    Rao M; Trivillin VA; Heber EM; Cantarelli Mde L; Itoiz ME; Nigg DW; Rebagliati RJ; Batistoni D; Schwint AE
    Appl Radiat Isot; 2004 Nov; 61(5):947-52. PubMed ID: 15308173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dosimetry and radiobiology at the new RA-3 reactor boron neutron capture therapy (BNCT) facility: application to the treatment of experimental oral cancer.
    Pozzi E; Nigg DW; Miller M; Thorp SI; Heber EM; Zarza L; Estryk G; Monti Hughes A; Molinari AJ; Garabalino M; Itoiz ME; Aromando RF; Quintana J; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S309-12. PubMed ID: 19380233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent.
    Matalka KZ; Bailey MQ; Barth RF; Staubus AE; Soloway AH; Moeschberger ML; Coderre JA; Rofstad EK
    Cancer Res; 1993 Jul; 53(14):3308-13. PubMed ID: 8324742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis.
    Ariyoshi Y; Miyatake S; Kimura Y; Shimahara T; Kawabata S; Nagata K; Suzuki M; Maruhashi A; Ono K; Shimahara M
    Oncol Rep; 2007 Oct; 18(4):861-6. PubMed ID: 17786347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
    Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
    Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liposomal boron delivery for neutron capture therapy.
    Nakamura H
    Methods Enzymol; 2009; 465():179-208. PubMed ID: 19913168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple genotypic aberrances associate to terminal differentiation-deficiency of an oral squamous cell carcinoma in serum-free culture.
    Roberg K; Ceder R; Farnebo L; Norberg-Spaak L; Grafström RC
    Differentiation; 2008 Oct; 76(8):868-80. PubMed ID: 18452551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro neutron irradiation of glioma and endothelial cultured cells.
    Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer.
    Zhang Z; Wang Y; Yao R; Li J; Lubet RA; You M
    Mol Cancer Res; 2006 Jun; 4(6):401-10. PubMed ID: 16778087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
    Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Boron neutron capture therapy for murine malignant gliomas.
    Saris SC; Solares GR; Wazer DE; Cano G; Kerley SE; Joyce MA; Adelman LS; Harling OK; Madoc-Jones H; Zamenhof RG
    Cancer Res; 1992 Sep; 52(17):4672-7. PubMed ID: 1511433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential of boron neutron capture therapy (BNCT) for malignant peripheral nerve sheath tumors (MPNST).
    Fujimoto T; Andoh T; Sudo T; Fujita I; Fukase N; Takeuchi T; Sonobe H; Inoue M; Hirose T; Sakuma T; Moritake H; Sugimoto T; Kawamoto T; Fukumori Y; Yamamoto S; Atagi S; Sakurai Y; Kurosaka M; Ono K; Ichikawa H; Suzuki M
    Appl Radiat Isot; 2015 Dec; 106():220-5. PubMed ID: 26278348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node.
    Kimura Y; Ariyoshi Y; Shimahara M; Miyatake S; Kawabata S; Ono K; Suzuki M; Maruhashi A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S47-9. PubMed ID: 19395269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of copper octabromotetracarboranylphenylporphyrin for boron neutron capture therapy and its toxicity and biodistribution in tumour-bearing mice.
    Miura M; Morris GM; Micca PL; Nawrocky MM; Makar MS; Cook SP; Slatkin DN
    Br J Radiol; 2004 Jul; 77(919):573-80. PubMed ID: 15238404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Boron neutron capture therapy (BNCT) selectively destroys human clear cell sarcoma in mouse model.
    Fujimoto T; Andoh T; Sudo T; Fujita I; Moritake H; Sugimoto T; Sakuma T; Akisue T; Kawabata S; Kirihata M; Suzuki M; Sakurai Y; Ono K; Fukumori Y; Kurosaka M; Ichikawa H
    Appl Radiat Isot; 2013 Mar; 73():96-100. PubMed ID: 23306161
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteomic analysis of cellular response induced by boron neutron capture reaction in human squamous cell carcinoma SAS cells.
    Sato A; Itoh T; Imamichi S; Kikuhara S; Fujimori H; Hirai T; Saito S; Sakurai Y; Tanaka H; Nakamura H; Suzuki M; Murakami Y; Baiseitov D; Berikkhanova K; Zhumadilov Z; Imahori Y; Itami J; Ono K; Masunaga S; Masutani M
    Appl Radiat Isot; 2015 Dec; 106():213-9. PubMed ID: 26302661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histamine reduces boron neutron capture therapy-induced mucositis in an oral precancer model.
    Monti Hughes A; Pozzi E; Thorp SI; Curotto P; Medina VA; Martinel Lamas DJ; Rivera ES; Garabalino MA; Farías RO; Gonzalez SJ; Heber EM; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
    Oral Dis; 2015 Sep; 21(6):770-7. PubMed ID: 25926141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of newly established oral squamous cell carcinoma; 33-bp deletion in exons 3-4 of the p53 tumor suppressor gene.
    Hwang YS; Kim HJ; Kim J; Park KK; Chung WY
    Oral Oncol; 2012 Nov; 48(11):e39-41. PubMed ID: 22776128
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.